Effect of a nationwide booster vaccine rollout in Israel on SARS-CoV-2 infection and severe illness in young adults
| Errataetall: |
CommentOn: N Engl J Med. 2021 Oct 7;385(15):1393-1400. - PMID 34525275 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Travel medicine and infectious disease - 44(2021) vom: 05. Nov., Seite 102195 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bomze, David [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 09.12.2021 Date Revised 21.12.2022 published: Print-Electronic CommentOn: N Engl J Med. 2021 Oct 7;385(15):1393-1400. - PMID 34525275 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tmaid.2021.102195 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332752461 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332752461 | ||
| 003 | DE-627 | ||
| 005 | 20231225220226.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tmaid.2021.102195 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1109.xml |
| 035 | |a (DE-627)NLM332752461 | ||
| 035 | |a (NLM)34737149 | ||
| 035 | |a (PII)S1477-8939(21)00236-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bomze, David |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of a nationwide booster vaccine rollout in Israel on SARS-CoV-2 infection and severe illness in young adults |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.12.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: N Engl J Med. 2021 Oct 7;385(15):1393-1400. - PMID 34525275 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Sprecher, Eli |e verfasserin |4 aut | |
| 700 | 1 | |a Gamzu, Ronni |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d 2003 |g 44(2021) vom: 05. Nov., Seite 102195 |w (DE-627)NLM16457655X |x 1873-0442 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2021 |g day:05 |g month:11 |g pages:102195 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tmaid.2021.102195 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2021 |b 05 |c 11 |h 102195 | ||